Antibiotics as environmental waste
Antibiotics, which are substances that inhibit the growth of or kill bacteria, are widely used in healthcare, agriculture, and various industries. However, their release into the environment as waste poses significant challenges, particularly the emergence of antibiotic-resistant bacteria. This resistance can develop through selective pressure, where bacteria mutate or acquire resistance genes, allowing them to survive exposure to antibiotics. The presence of antibiotics in aquatic and terrestrial environments often results from agricultural runoff, wastewater discharges, and improper disposal of medical waste, leading to the contamination of food and water supplies.
The consequences of antibiotic resistance are profound, impacting public health by complicating the treatment of infections. Resistant bacteria can spread through various pathways, including direct contact with contaminated food or water, or indirectly through environmental interactions. The global nature of trade and agriculture further exacerbates the situation, making it a worldwide concern. As antibiotic-resistant infections become more prevalent, they lead to increased morbidity, mortality, and healthcare costs, emphasizing the need for effective strategies to manage antibiotic use and mitigate environmental contamination.
Antibiotics as environmental waste
DEFINITION: Molecules that inhibit the growth of or kill bacteria
Antibiotics are used routinely in health care, industry, and agriculture to treat and prevent bacterial infections. Antibiotics released into the environment as waste can generate bacteria that are resistant to the antibiotics through the process of selective pressure. These antibiotic-resistant bacteria can enter the food chain and can indirectly or directly promote the generation of antibiotic-resistant bacteria pathogens.
Antibiotics are defined as bacteriostatic or bactericidal substances that can inhibit the growth of or kill bacteria, respectively. Antibiotics can range from those isolated as natural compounds, such as aminoglycosides, to those that are completely synthetic, such as quinolones. The first modern was penicillin, discovered by scientist Alexander Fleming in 1928; Fleming was later awarded the Nobel Prize for his contributions to medical science. Antibiotics work by inhibiting essential processes in cells, leading to the inhibition of growth or death of the target bacterium. For example, the bactericidal beta-lactam antibiotics such as penicillin work by inhibiting transpeptidase enzymes, which play an important role in synthesis of the protective peptidoglycan layer of the bacterial cell envelope. The bacteriostatic agent chloramphenicol inhibits protein synthesis by binding to the 50S subunit of the ribosome and interfering with peptide bond formation.
While various in vitro microbiological techniques may indicate whether or not a particular antibiotic is bacteriostatic or bactericidal, the antibiotic’s clinical usefulness is dependent on other factors. These include the antibiotic’s pharmacokinetic and pharmacodynamic characteristics as well as the host’s state of health and immune system defense mechanisms. Antibiotics can generally be categorized as either narrow-spectrum or broad-spectrum. Narrow-spectrum antibiotics target certain families of bacteria, whereas broad-spectrum antibiotics can treat a wide variety of pathogens and also affect environmental bacteria.
Antibiotics have their origin in nature as molecules that are secreted by one type of to inhibit thegrowth of a competitor. It is believed that antibiotic-producing bacteria are the origin of antibiotic genes, since these organisms must have the capacity to resist the effects of the antibiotics they produce.
Antibiotics and the Environment
Antibiotics are widely used by humans in clinical settings and to treat or prevent bacterial infections in companion and food animals. The Animal Health Institute and the Union of Concerned Scientists have estimated that in the United States alone, several million pounds of antibiotics are consumed per year in the treatment of humans and livestock. Antibiotics, especially nonbiodegradable antibiotics, can enter aquatic and terrestrial environments through avenues such as farms, wastewater, and animal manure containing these drugs. For example, a Norwegian study that investigated the of pharmaceuticals in the effluent from two Oslo hospitals found that detectable levels of several antibiotics were present in both hospitals’ wastewater. Furthermore, the same study showed that and samples from a wastewater treatment works that serves the region contained detectable amounts of most of the antibiotics found in the hospital wastewater. Effluent samples from the treatment works contained reduced amounts of antibiotics; however, the levels of the antibiotic trimethoprim were higher in the effluent than in the influent samples. High levels of the antibiotic ciprofloxacin were found in the sludge samples. Antibiotics released into the have the potential to generate harmful and possibly deadly antibiotic-resistant bacteria.
Antibiotic-Resistant Bacteria
Antibiotic resistance in a bacterium can be the result of a random mutation in the target or the transfer of antibiotic resistance genes from one bacterium to another. A random mutation can result in the positive selection of bacterial mutants resistant to the antibiotic. Another route whereby bacteria can gain resistance is through horizontal gene transfer (HGT). During HGT, a bacterium can gain an antibiotic resistance gene through transformation, transduction, or conjugation. In most bacteria, the major route of transmission of antibiotic resistance genes is through the conjugation of plasmids, which are extra chromosomal pieces of deoxyribonucleic acid (DNA) that are capable of autonomous replication. It is important to note that HGT can occur almost anywhere that bacteria exist, including the environment and the human gastrointestinal tract.
One example of an antibiotic resistance gene is the bla gene, which codes for the TEM-1 beta-lactamase enzyme. Beta-lactamases such as TEM-1 can cleave the beta-lactam ring of beta-lactam antibiotics such as ampicillin. This cleavage results in the inactivation of the antibiotic. In an effort to increase the efficacy of some antibiotic drugs, some manufacturers add to antibiotic preparations other compounds that play a role in inactivating the biochemical mechanism in the resistant bacteria that degrades the antibiotic. For example, the drug Augmentin is a mixture of amoxicillin (a beta-lactam-containing antibiotic) and potassium clavulanate. The clavulanate is a beta-lactamase inhibitor—that is, it inhibits the beta-lactamase that would cleave amoxicillin and render it ineffective.
Any type of resistance to antibiotics that is gained by a bacterial as a result of selective pressure by the population’s natural is called intrinsic resistance. Acquired resistance by bacteria, in contrast, is brought about as a result of antibiotic use by humans; such acquired resistance has been involved in the development of antibiotic-resistant human pathogens.
Dissemination of Antibiotic-Resistant Bacteria
The dissemination of antimicrobial resistance is not restricted by geographic, phylogenetic, or ecological boundaries, especially given the global economy of the modern world. The use of antibiotics in one ecological niche, such as in agriculture or aquaculture, may give rise to antimicrobial resistance in other ecological niches, such as the human environment. The spread of resistance can be indirect, such as through the horizontal transfer of resistance genes through plasmids, or direct, where antibiotic-resistant bacteria are transferred by direct contact with humans. An example of indirect transfer comes from a study that showed that a encoding for cephalothin resistance was transferable to Escherichia coli (E. coli), a bacteria in the human gut, from Vibrio strains found in a shrimp pond. Direct transfer can include the intake of harmful antibiotic-resistant bacteria from contaminated drinking water, food animal sources (such as chickens and turkeys), and vegetables.
Infections caused by antibiotic-resistant bacteria present a special challenge to physicians, especially in health care settings. Poor hygiene practices in hospitals (such as failure to decontaminate surgical or respiratory equipment), nursing homes, and dialysis centers have led to the spread and promotion of multidrug-resistant (MDR) bacteria, which usually have resistance to three or more antibiotics. One study on burn patients who had been hospitalized for a long period of time in an intensive care unit showed that the patients carried significantly more MDR bacteria than they had on admission. Methicillin-resistant Staphylococcus aureus (or MRSA) is resistant to a wide variety of beta-lactam antibiotics and has become a highly adaptable, drug-resistant that kills about seventeen thousand hospital patients per year. Antibiotic resistance increases and from infectious diseases as well as the costs of treating such diseases. With the lack of many new antibiotics on the horizon, antibiotic resistance poses a serious public health dilemma.
Bibliography
Heuer, Ole E., et al. “Human Health Consequences of Use of Antimicrobial Agents in Aquaculture.” Clinical Infectious Diseases 49 (2009): 1248-1253.
Keen, Edward F., III, et al. “Prevalence of Multidrug-Resistant Organisms Recovered at a Military Burn Center.” Burns: Journal of the International Society for Burn Injuries (January, 2010).
Martinez, Jose L. “The Role of Natural Environments in the Evolution of Resistance Traits in Pathogenic Bacteria.” Proceedings of the Royal Society B 276 (2009): 2521-2530.
Polianciuc, Svetlana Iuliana, et al. "Antibiotics in the Environment: Causes and Consequences." Medicine and Pharmacy Reports, vol. 93, no. 3, 22 July 2020, pp. 231–240, doi: 10.15386/mpr-1742. Accessed 12 July 2024.
Rice, Louis B. “The Clinical Consequences of Antimicrobial Resistance.” Current Opinion in Microbiology 12 (2009): 476-481.
Sachs, Jessica Snyder. Good Germs, Bad Germs: Health and Survival in a Bacterial World. New York: Hill & Wang, 2007.
Thomas, Kevin V., et al. “Source to Sink Tracking of Selected Human Pharmaceuticals from Two Oslo City Hospitals and a Wastewater Treatment Works.” Journal of Environmental Monitoring 9 (2007): 1410-1418.
Walsh, Christopher. Antibiotics: Actions, Origins, Resistance. Washington, D.C.: ASM Press, 2003.